Search

everythinglearnresearchcommunity

for

Search:↓

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Skin issues can indicate immune system problems.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Voriconazole can cause serious side effects, especially in long-term use.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Lactic acid cream can help improve skin bumps known as eruptive vellus hair cysts.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document explains various skin conditions and their treatments.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Different types of fibroblasts play various roles in diseases and healing, and more research on them could improve treatments.

Special fiber materials boost the healing properties of certain stem cells.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

The shape of fibrous scaffolds can improve how stem cells help heal skin.